1.415

2.55% 0.045

Mindwalk Holdings Corp (HYFT)

Overview News Price History Discussions Forecast

Mindwalk Holdings Corp stock is traded at $1.415, with a volume of 81,306. It is up +2.55% in the last 24 hours and down -42.42% over the past month. MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Previous Close:

$1.37

Open:

$1.41

24h Volume:

81,306

Relative Volume:

0.18

Market Cap:

$65.83M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

-10.51%

1M Performance:

-42.42%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$1.38

$1.4497

1-Week Range:

$1.355

$1.6483

52-Week Range:

$1.355

$2.99

Mindwalk Holdings Corp Stock (HYFT) Company Profile

Name

Mindwalk Holdings Corp

Sector

Healthcare (1116)

Industry

Biotechnology (621)

Phone

Address

Employee

102

Twitter

Next Earnings Date

Latest SEC Filings

HYFT's Discussions on Twitter

Compare HYFT vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HYFT Mindwalk Holdings Corp	1.41	63.97M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	490.29	117.98B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	797.43	82.85B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	847.40	51.58B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	313.24	40.75B	3.21B	43.57M	221.36M	0.2405
ONC Beone Medicines Ltd Adr	351.00	38.33B	4.98B	69.60M	525.67M	0.5198

Mindwalk Holdings Corp Stock (HYFT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-02-22	Initiated	H.C. Wainwright	Buy
Oct-25-21	Initiated	The Benchmark Company	Buy

Mindwalk Holdings Corp Stock (HYFT) Latest News

Jan 27, 2026

MindWalk Uses HYFT AI Platform to Expose Hidden Portfolio and IP Risks in Drug Discovery - TipRanks

Jan 27, 2026

MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Yahoo Finance

Jan 27, 2026

Jan 26, 2026

MindWalk Launches HYFT Technology to Address Drug Development Risks - intellectia.ai

Jan 26, 2026

Jan 22, 2026

After Leaping 47% MindWalk Holdings Corp. (NASDAQ:HYFT) Shares Are Not Flying Under The Radar - 富途牛牛

Jan 22, 2026

Jan 15, 2026

MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease - BioSpace

Jan 15, 2026

Jan 14, 2026

Mindwalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic Tdp-43 in Neurodegenerative Disease - marketscreener.com

Jan 14, 2026

Jan 12, 2026

Scientists trace a hidden flu constraint across strains and hosts - Stock Titan

Jan 12, 2026

REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - Yahoo Finance

Jan 12, 2026

Jan 11, 2026

MindWalk (HYFT) Makes Progress in Influenza Research with Key Di - GuruFocus

Jan 11, 2026

Jan 10, 2026

MindWalk Holdings Corp. Advances Universal Influenza Program with A Breakthrough Functional Insight - marketscreener.com

Jan 10, 2026

Jan 09, 2026

MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - 01net

Jan 09, 2026

MindWalk Unveils Cross-Strain Functional Constraint to Advance Universal Flu Vaccine Effort - TipRanks

Jan 09, 2026

MindWalk : Charter of the Audit Committee of the Board of Directors - marketscreener.com

Jan 09, 2026

MindWalk Holdings Corp.'s (NASDAQ:HYFT) P/S Is Still On The Mark Following 38% Share Price Bounce - Sahm

Jan 09, 2026

Jan 06, 2026

MindWalk Holdings Corp. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYFT) 2025-12-18 - Seeking Alpha

Dec 18, 2025

Dec 17, 2025